Focused Alpha’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$608K Buy
21,310
+87
+0.4% +$2.31K 0.15% 126
2026
Q2
$511K Buy
21,223
+321
+2% +$8.4K 0.13% 149
2026
Q1
$587K Buy
20,902
+35
+0.2% +$932 0.18% 116
2025
Q4
$520K Buy
+20,867
New +$526K 0.15% 136

Other funds holding PFE

Focused Alpha's PFE Position: Q3 2026 in Review

Focused Alpha increased its Pfizer (PFE) stake by 0.41% in Q3 2026, buying an estimated $2.31K and bringing the position to 21,310 shares worth $608K. The position accounts for 0.15% of the portfolio, ranked #126.

Focused Alpha first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Focused Alpha held 21,310 shares of Pfizer worth $608K as of Q3 2026.
  • Focused Alpha bought 87 Pfizer shares in Q3 2026, an estimated $2.31K.
  • Pfizer made up 0.15% of Focused Alpha's portfolio in Q3 2026, its #126 holding.
  • Focused Alpha first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.